Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis

References

• Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–363.
   PubMed Web of Science ®Google Scholar
• Dehal A, Smith JJ, Nash GM, et al. Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future. J Gastrointest Oncol. 2016;7(1):143–157.
   PubMedGoogle Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42.
   PubMed Web of Science ®Google Scholar
• Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237–6242.
   PubMed Web of Science ®Google Scholar
• Levine EA, Stewart JH, Shen P, et al. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218(4):573–585.
   PubMed Web of Science ®Google Scholar
• Chua TC, Yan TD, Smigielski ME, et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol. 2009;16(7):1903–1911.
   PubMed Web of Science ®Google Scholar
• Kuijpers AMJ, Mirck B, Aalbers AGJ, et al. Cytoreduction and HIPEC in The Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol. 2013;20(13):4224–4230.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Turaga KK, Alexander HR, et al. Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy. J Oncol Pract. 2016;12(10):928–935.
   PubMed Web of Science ®Google Scholar
• Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449–2456.
   PubMed Web of Science ®Google Scholar
• Grotz TE, Overman MJ, Eng C, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for moderately and poorly differentiated appendiceal adenocarcinoma: survival outcomes and patient selection. Ann Surg Oncol. 2017;24(9):2646–2654.
   PubMed Web of Science ®Google Scholar
• Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22(5):1686–1693.
   PubMed Web of Science ®Google Scholar
• Omohwo C, Nieroda CA, Studeman KD, et al. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg. 2009;209(3):308–312.
   PubMed Web of Science ®Google Scholar
• Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608–5618.
   PubMed Web of Science ®Google Scholar
• Kyang LS, Alzahrani NA, Valle SJ, et al. Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: single-institutional experience with 1225 cases. J Surg Oncol. 2019;120(4):794–802.
   PubMed Web of Science ®Google Scholar
• Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28(1):63–68.
   PubMed Web of Science ®Google Scholar
• Glehen O, Mohamed F, Sugarbaker PH, et al. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240(2):278–285.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Update on the management of malignant peritoneal mesothelioma. Transl Lung Cancer Res. 2018;7(5):599–608.
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–188.
   PubMed Web of Science ®Google Scholar
• Misdraji J, Carr NJ, Pai RK. Appendiceal mucinous neoplasm. In: WHO classification of tumours: digestive system tumours. WHO Classification of Tumour Editorial Board (Ed), Lyon, France: IARC; 2019.
   Google Scholar
• World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.
   Google Scholar
• Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–374.
   PubMedGoogle Scholar
• Dindo D, Demartines N, Clavien P-A, et al. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.
   PubMed Web of Science ®Google Scholar
• Benhaim L, Faron M, Gelli M, et al. Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei. Surg Oncol. 2019;29:78–83.
   PubMed Web of Science ®Google Scholar
• Huang Y, et al. Clinical outcomes of patients with extensive peritoneal carcinomatosis following cytoreductive surgery and perioperative intraperitoneal chemotherapy. Anticancer Res. 2016;36:1033–1040.
   PubMed Web of Science ®Google Scholar
• Didelot C, Lanneau D, Brunet M, et al. Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr Med Chem. 2007;14(27):2839–2847.
   PubMed Web of Science ®Google Scholar
• Jimenez W, Sardi A, Nieroda C, et al. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2014;21(13):4218–4225.
   PubMed Web of Science ®Google Scholar
• Votanopoulos KI, Bartlett D, Moran B, et al. PCI is not predictive of survival after complete CRS/HIPEC in peritoneal dissemination from high-grade appendiceal primaries. Ann Surg Oncol. 2018;25(3):674–678.
   PubMed Web of Science ®Google Scholar
• El Halabi H, Gushchin V, Francis J, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19(1):110–114.
   PubMed Web of Science ®Google Scholar
• Polanco PM, Ding Y, Knox JM, et al. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in patients with high-grade, high-volume disseminated mucinous appendiceal neoplasms. Ann Surg Oncol. 2016;23(2):382–390.
   PubMed Web of Science ®Google Scholar
• Kitai T, Yamanaka K, Sugimoto N, et al. Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden. Surg Today. 2020;50(2):171–177.
   PubMed Web of Science ®Google Scholar
• Chua TC, Liauw W, Morris DL, et al. Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis. 2012;27(3):381–389.
   PubMed Web of Science ®Google Scholar
• Chua TC, Al-Zahrani A, Saxena A, et al. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation. J Am Coll Surg. 2010;211(4):526–535.
   PubMed Web of Science ®Google Scholar
• McConnell YJ, Mack LA, Francis WP, et al. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol. 2013;107(6):591–596.
   PubMed Web of Science ®Google Scholar
• Tan GHC, Ong WS, Chia CS, et al. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? Int J Hyperthermia. 2016;32(3):281–288.
   PubMed Web of Science ®Google Scholar
• Huang Y, Alzahrani NA, Liauw W, et al. Early postoperative intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasms with pseudomyxoma peritonei: is it beneficial? Ann Surg Oncol. 2017;24(1):176–183.
   PubMed Web of Science ®Google Scholar
• Kyang LS, Alzahrani NA, Alshahrani MS, et al. Early recurrence in peritoneal metastasis of appendiceal neoplasm: survival and prognostic factors. Eur J Surg Oncol. 2019;45(12):2392–2397.
   PubMed Web of Science ®Google Scholar
• Baratti D, Kusamura S, Martinetti A, et al. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2007;14(8):2300–2308.
   PubMed Web of Science ®Google Scholar
• Cata JP, Wang H, Gottumukkala V, et al. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth. 2013;110(5):690–701.
   PubMed Web of Science ®Google Scholar
• Nizri E, Kusamura S, Fallabrino G, et al. Dose-dependent effect of red blood cells transfusion on perioperative and long-term outcomes in peritoneal surface malignancies treated with cytoreduction and HIPEC. Ann Surg Oncol. 2018;25(11):3264–3270.
   PubMed Web of Science ®Google Scholar
• Chua TC, Yan TD, Saxena A, et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality. Ann Surg. 2009;249(6):900–907.
   PubMed Web of Science ®Google Scholar
• Huang Y, Alzahrani NA, Liauw W, et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis. ANZ J Surg. 2017;87(1–2):49–54.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Baratti D, Deraco M, et al. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies. Ann Surg. 2012;255(2):348–356.
   PubMed Web of Science ®Google Scholar